Precedent Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Buy
377
+56
+17% +$57.2K 0.08% 151
2026
Q1
$295K Sell
321
-13
-4% -$13.2K 0.06% 147
2025
Q4
$359K Buy
334
+58
+21% +$55.5K 0.08% 145
2025
Q3
$211K Sell
276
-18
-6% -$13.4K 0.05% 165
2025
Q2
$229K Buy
294
+39
+15% +$30.3K 0.06% 162
2025
Q1
$211K Buy
+255
New +$212K 0.06% 151

Other funds holding LLY

Precedent Wealth Partners's LLY Position: Q2 2026 in Review

Precedent Wealth Partners increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $57.2K and bringing the position to 377 shares worth $452K. The position accounts for 0.08% of the portfolio, ranked #151.

Precedent Wealth Partners first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Precedent Wealth Partners held 377 shares of Eli Lilly worth $452K as of Q2 2026.
  • Precedent Wealth Partners bought 56 Eli Lilly shares in Q2 2026, an estimated $57.2K.
  • Eli Lilly made up 0.08% of Precedent Wealth Partners's portfolio in Q2 2026, its #151 holding.
  • Precedent Wealth Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Precedent Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.